PROTAC sEH degrader-2
PROTAC sEH degrader-2 is a PROTAC targeting degradation agent for soluble epoxide hydrolase (sEH) with pIC50 values of the catalytic domain of 8.37 (human sEH-H) and 7.12 (mouce sEH-H). PROTAC sEH degrader-2 can be used for the research related to inflammation and neuroinflammation, such as Alzheimer's disease[1]. (Structure Note: Pink: sEH-H ligand ; Blue: CRBN Ligand (HY-103597) ; Black: linker; E3 + linker (HY-141011) )
Product Specifications
UNSPSC
12352100
Target
Epoxide Hydrolase; PROTACs
Related Pathways
Metabolic Enzyme/Protease; PROTAC
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
O=C(NCC1=C(C=C(C=C1)NS(=O)(CCCC2=CN(N=N2)CCOCCOCCOCCOCCNC(COC3=C(C(N(C4C(NC(CC4)=O)=O)C5=O)=O)C5=CC=C3)=O)=O)C(F)(F)F)C6=CC=C7N(C=CC7=C6)CC8=CC=CC(F)=C8
Molecular Formula
C54H57F4N9O13S
Molecular Weight
1148.14
References & Citations
[1]Schönfeld J, et al. Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase. J Med Chem. 2025 Jul 10;68 (13) :13728-13749.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470043-100 1x 100 µL
P21 / WAF1 (WA-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682038-500 1x 500 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2038), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041067-100 1x 100 µL
HLA-DRB (HLA-DRB/1067), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details